TURNING POINT THERAPEUTICS I filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by TURNING POINT THERAPEUTICS I (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2022-02-14PRICE T ROWE ASSOCIATES INC /MD/Turning Point Therapeutics, Inc.3,811,5687.7%EDGAR
SC 13G2022-02-14Cormorant Asset Management, LPTurning Point Therapeutics, Inc.1,540,780-EDGAR
SC 13G/A2022-02-10VANGUARD GROUP INCTurning Point Therapeutics, Inc.3,877,3397.8%EDGAR
SC 13G/A2022-02-09FMR LLCTurning Point Therapeutics, Inc.1,398,6022.8%EDGAR
SC 13G2022-02-04WELLINGTON MANAGEMENT GROUP LLPTurning Point Therapeutics, Inc.4,009,6548.1%EDGAR
SC 13G/A2022-02-03BlackRock Inc.Turning Point Therapeutics, Inc.3,783,3257.6%EDGAR
SC 13G/A2021-06-10FMR LLCTurning Point Therapeutics, Inc.3,173,6696.5%EDGAR
SC 13D/A2021-04-07ORBIMED ADVISORS LLCTurning Point Therapeutics, Inc.1,743,9503.6%EDGAR
SC 13G/A2021-02-16Cormorant Asset Management, LPTurning Point Therapeutics, Inc.821,435-EDGAR
SC 13G2021-02-16PRICE T ROWE ASSOCIATES INC /MD/Turning Point Therapeutics, Inc.2,545,7855.2%EDGAR
SC 13G/A2021-02-10VANGUARD GROUP INCTurning Point Therapeutics, Inc.3,440,4607.1%EDGAR
SC 13G/A2021-02-08FMR LLCTurning Point Therapeutics, Inc.6,215,36212.9%EDGAR
SC 13G/A2021-02-01BlackRock Inc.Turning Point Therapeutics, Inc.3,157,3876.6%EDGAR
SC 13D/A2020-11-06GLAXOSMITHKLINE PLCTurning Point Therapeutics, Inc.2,273,6184.9%EDGAR
SC 13D/A2020-05-26GLAXOSMITHKLINE PLCTurning Point Therapeutics, Inc.2,268,6605.5%EDGAR
SC 13D/A2020-05-22ORBIMED ADVISORS LLCTurning Point Therapeutics, Inc.2,027,5504.9%EDGAR
SC 13G/A2020-02-14Cormorant Asset Management, LPTurning Point Therapeutics, Inc.1,733,498-EDGAR
SC 13G/A2020-02-14Foresite Capital Fund IV, L.P.Turning Point Therapeutics, Inc.00.0%EDGAR
SC 13G2020-02-11VANGUARD GROUP INCTurning Point Therapeutics, Inc.1,965,2345.5%EDGAR
SC 13G/A2020-02-07FMR LLCTurning Point Therapeutics, Inc.4,840,64613.5%EDGAR
External links